8P43
 
 | |
5LLL
 
 | Crystal structure of DACM wild type Transthyretin | Descriptor: | Transthyretin | Authors: | Sala, B.M, Ghadami, S.A, Bemporad, F, Chiti, F, Ricagno, S. | Deposit date: | 2016-07-27 | Release date: | 2017-06-07 | Last modified: | 2024-01-10 | Method: | X-RAY DIFFRACTION (1.42 Å) | Cite: | FRET studies of various conformational states adopted by transthyretin. Cell. Mol. Life Sci., 74, 2017
|
|
5LLV
 
 | Crystal structure of DACM F87M/L110M Transthyretin mutant | Descriptor: | ACETATE ION, CHLORIDE ION, Transthyretin | Authors: | Sala, B.M, Ghadami, S.A, Bemporad, F, Chiti, F, Ricagno, S. | Deposit date: | 2016-07-28 | Release date: | 2017-06-07 | Last modified: | 2024-01-10 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | FRET studies of various conformational states adopted by transthyretin. Cell. Mol. Life Sci., 74, 2017
|
|
5CKA
 
 | Human beta-2 microglobulin double mutant W60G-N83V | Descriptor: | ACETATE ION, Beta-2-microglobulin, DI(HYDROXYETHYL)ETHER, ... | Authors: | Sala, B.M, De Rosa, M, Bolognesi, M, Ricagno, S. | Deposit date: | 2015-07-15 | Release date: | 2016-05-18 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability. Sci Rep, 6, 2016
|
|
5CKG
 
 | Human beta-2 microglobulin mutant V85E | Descriptor: | ACETATE ION, Beta-2-microglobulin, GLYCEROL | Authors: | Sala, B.M, De Rosa, M, Bolognesi, M, Ricagno, S. | Deposit date: | 2015-07-15 | Release date: | 2016-05-18 | Last modified: | 2024-11-20 | Method: | X-RAY DIFFRACTION (1.75 Å) | Cite: | Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability. Sci Rep, 6, 2016
|
|
5CFH
 
 | |
8RNE
 
 | HLA-E*01:03 in complex with SARS-CoV-2 Nsp13 peptide, VMPLSAPTL | Descriptor: | Beta-2-microglobulin, HLA class I histocompatibility antigen, E alpha chain variant, ... | Authors: | Sun, R, Achour, A, Sala, B.M, Sandalova, T. | Deposit date: | 2024-01-09 | Release date: | 2024-12-04 | Last modified: | 2025-01-22 | Method: | X-RAY DIFFRACTION (1.71 Å) | Cite: | Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness. Plos Pathog., 20, 2024
|
|
8RNF
 
 | HLA-E*01:03 in complex with SARS-CoV-2 Omicron Nsp13 peptide, VIPLSAPTL | Descriptor: | Beta-2-microglobulin, HLA class I histocompatibility antigen, E alpha chain variant, ... | Authors: | Sun, R, Achour, A, Sala, B.M, Sandalova, T. | Deposit date: | 2024-01-09 | Release date: | 2024-12-04 | Last modified: | 2025-01-22 | Method: | X-RAY DIFFRACTION (1.872 Å) | Cite: | Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness. Plos Pathog., 20, 2024
|
|
9GN3
 
 | |